Sign Up to like & get
recommendations!
0
Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.8032
Abstract: 8032Background: The phase 3 ENDEAVOR trial demonstrated significantly improved PFS and OS with Kd56 vs Vd in RRMM patients (pts; Dimopoulos Lancet Oncol 2016 and 2017). We report updated data after...
read more here.
Keywords:
endeavor;
carfilzomib dexamethasone;
dexamethasone kd56;
dexamethasone ... See more keywords